Journal
VIRULENCE
Volume 3, Issue 5, Pages 440-445Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/viru.21302
Keywords
VP24; interferon antagonist; ebolavirus; Ebola virus; VP35; STAT1; karyopherin alpha proteins; IFN alpha; IFN beta; IFN gamma; X-ray crystallography; crystal structures
Categories
Funding
- Skaggs Institute for Chemical Biology
- NIH [AI081982, AI2008031, GM020501, GM066170, NS070899, GM093325, RR029388, 5P32 AI007244]
Ask authors/readers for more resources
Suppression during the early phases of the immune system often correlates directly with a fatal outcome for the host. The ebolaviruses, some of the most lethal viruses known, appear to cripple initial stages of the host defense network via multiple distinct paths. Two of the eight viral proteins are critical for immunosuppression. One of these proteins is VP35, which binds double-stranded RNA and antagonizes several antiviral signaling pathways.(1,2) The other protein is VP24, which binds transporter molecules to prevent STAT1 translocation.(3) A more recent discovery is that VP24 also binds STAT1 directly,(4) suggesting that VP24 may operate in at least two separate branches of the interferon pathway. New crystal structures of VP24 derived from pathogenic and nonpathogenic ebolaviruses reveal its novel, pyramidal fold, upon which can be mapped sites required for virulence and for STAT1 binding. These structures of VP24, and new information about its direct binding to STAT1, provide avenues by which we may explore its many roles in the viral life cycle, and reasons for differences in pathogenesis among the ebolaviruses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available